Review paper
Targeted therapy of hepatocellular cancer
Volume: 19, Issue: 2, Pages: 265 - 274
Published: Jan 15, 2010
Abstract
Hepatocellular cancer (HCC) is the fifth most common malignancy worldwide and third leading cause of cancer death. HCC is highly resistant to conventional systemic therapies, and prognosis for advanced HCC patients remains poor. However, identification of signaling pathways responsible for HCC growth and progression such as RAS/RAF/MEK/ERK or PI3K/AKT/mTOR has determined crucial molecular targets and led to development of novel promising...
Paper Details
Title
Targeted therapy of hepatocellular cancer
Published Date
Jan 15, 2010
Volume
19
Issue
2
Pages
265 - 274
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History